YZYuansong Zhuang

Yuansong Zhuang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yuansong Zhuang has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparative Analysis of Surrogate Insulin Resistance Indexes in Cardiometabolic Multimorbidity: A Cross-Sectional Study

    by Jinyan Lei, Yuansong Zhuang, Xinlong Zhao, Yuxiong Chen, Siqi Tang, Yitao Han, Yakun Zhao, Yanbo Liu, Zhongjie Fan

    Background:Cardiometabolic multimorbidity (CMM), defined as the coexistence of two or more cardiometabolic diseases, poses an increasing challenge to global health. Although various surrogate indexes of insulin resistance (IR) exist, current evidence lacks a systematic comparison of the related strength of association with CMM. Therefore, this study aimed to systematically evaluate 12 IR surrogates to determine the associated discriminative ability for detecting CMM.Methods:The analytical cohort comprised 9756 eligible participants from the National Health and Nutrition Examination Survey (NHANES) conducted between 1999 and 2020. The 12 IR surrogates were examined using multivariable logistic regression to assess the related associations with CMM. Nonlinear relationships were examined with restricted cubic splines, and discriminatory power was evaluated through the area under the curve (AUC) from receiver operating characteristic (ROC) analysis.Results:Among 9756 eligible participants, 4383 (44.9%) were identified with CMM. Multivariable logistic regression-adjusted models revealed that odds ratios (ORs) for CMM progressively increased with ascending quartiles of all IR surrogates. After full adjustment, the ORs of homeostatic model assessment of insulin resistance (HOMA-IR) were as follows: Q2: OR = 1.78, 95% confidence interval (CI): 1.48–2.14; Q3: OR = 3.60, 95% CI: 2.82–4.60; Q4: OR = 8.80, 95% CI: 7.31–10.60. For triglyceride-glucose (TyG)-a body shape index (TyG-ABSI), the corresponding ORs were: Q2: OR = 2.51, 95% CI: 2.04–3.11; Q3: OR = 4.93, 95% CI: 3.98–6.10; Q4: OR = 11.02, 95% CI: 8.86–13.71. Nonlinear associations were observed for 11 of the 12 IR indexes, whereas TyG-ABSI exhibited linear dose–response relationships. TyG-ABSI outperformed other markers in the ROC analyses with an AUC of 0.764. These findings remained robust across multiple sensitivity analyses.Conclusions:TyG-ABSI is a reliable and cost-effective indicator associated with CMM risk, supporting the subsequent utility in distinguishing higher-risk individuals.

  • Urban greening as a potential nature-based solution for heat-related health burden: Evidence from acute myocardial infarction in a megacity

    by Yuansong Zhuang, Zhen He, Dongyang Pan, Yakun Zhao, Yuxiong Chen, Yitao Han, Siqi Tang, Chenglin Li, Jinyan Lei, Otthein Herzog, et al.

  • Open Access

    Short‐Term Exposure to Ambient Ozone and Fine Particulate Matter and Its Components Increases the Risk of In‐Hospital Adverse Outcomes in Patients With Acute Myocardial Infarction: A Time‐Stratified Case‐Crossover Study

    by Yuansong Zhuang, Yakun Zhao, Yuxiong Chen, Siqi Tang, Yanbo Liu, Xinlong Zhao, Yitao Han, Jinyan Lei, Zhongjie Fan

    Background: Although exposure to ozone (O 3 ) and fine particulate matter with a diameter of ≤2.5 μm (PM 2.5 ) has been associated with increased cardiovascular events and hospitalizations, their association with in‐hospital outcomes among patients with acute myocardial infarction remains uncertain. Methods: A time‐stratified case‐crossover study was conducted using patients with acute myocardial infarction admitted to hospitals in Beijing from 2013 to 2019. Daily levels of O 3 and PM 2.5 and its components (sulfate, nitrate, ammonium, organic matter, and black carbon) were assessed. Conditional logistic regression estimated exposure–response relationships between pollutants and in‐hospital death. The relative excess risk due to interaction was used to quantify interactions between O 3 and each PM 2.5 component. Results: O 3 exhibited a threshold effect: When the concentration on the admission day exceeded 90 μg/m 3 , in‐hospital mortality risk increased significantly. PM 2.5 and each component showed linear exposure–response relationships. At a 2‐day moving average, each 10 μg/m 3 increase in PM 2.5 was associated with a 1.4% (95% CI, 0.9%–1.9%) increase in in‐hospital death. Significant positive multiplicative interactions were observed between O 3 and all PM 2.5 components, with notable synergistic effects for O 3 –organic matter (relative excess risk due to interaction, 0.155 [95% CI, 0.053–0.258]) and O 3 –black carbon (relative excess risk due to interaction, 0.137 [95% CI, 0.033–0.240]). The effects of O 3 were stronger in summer, while the effects of PM 2.5 components were more pronounced in winter. Joint exposure resulted in a higher mortality burden than single‐pollutant exposure. Conclusions: Short‐term exposure to O 3 and PM 2.5 components increases in‐hospital mortality risk in patients with acute myocardial infarction, with synergistic effects between ozone and organic matter or O 3 and black carbon.


  • The role of circulating biomarkers in predicting the 30-day mortality of immune checkpoint inhibitors-related myocarditis: a retrospective cohort study

    by Yuansong Zhuang, Quanxu An, Fuhang Wang, Dongjian Han, Zhentao Qiao, Qingjiao Jiang, Miaomiao Liu, Yuhang Li, Jiahong Shangguan, Xuanye Bi, et al.

    Immune checkpoint inhibitors-related myocarditis (ICIs-M) is a rare and highly lethal immune-related adverse events (irAEs) in common irAEs. This study aims to find circulating biomarkers that can reflect disease state and prognosis accurately. 48 patients with ICIs-M were enrolled according to the diagnostic criteria for ICIs-related myocarditis. For all enrolled patients, valuable information was extracted retrospectively from the medical system, mainly including demographic information, tumor information and laboratory examination. The follow-up period was defined as 30 days after the first diagnosis of ICIs-M. In this study, the 30-day mortality rate of ICIs-M was 24.4%. After adjusting for potential confounding factors using multivariate analysis tools, we demonstrated the excellent performance of biomarkers in predicting 30-day mortality in patients with ICIs-M, including PLT (hazard ratio (HR), 1.07; 95% confidence interval (95%CI), 1.01–1.14; p = 0.028), ALT (HR, 1.23; 95%CI, 1.06–1.41; p = 0.005), AST(HR, 1.06; 95%CI, 1.01–1.10; p = 0.015), LDH (HR, 1.15; 95%CI, 1.04–1.26; p = 0.004), troponin I(HR, 1.44; 95%CI, 1.09–1.89; p = 0.009), PLR (blood plate/lymphocyte) (HR, 1.04; 95% CI, 1.01–1.07; p = 0.024), LAR (lactate dehydrogenase/albumin) (HR, 1.05; 95%CI, 1.01–1.09; p = 0.012), and AAR (aspartate transaminase/albumin) (HR, 1.18; 95%CI, 1.00–1.39; p = 0.048). The analysis of the receiver operating characteristic showed that biomarkers with area under curve (AUC) greater than or equal to 0.80 were LDH (cutoff value, 724.5; AUC, 0.86; 95%CI, 0.75–0.97), LAR (cutoff value, 18.11; AUC, 0.87; 95%CI, 0.76–0.97), troponin I (cutoff value, 0.87; AUC, 0.80; 95%CI, 0.62–0.99), and AAR(cutoff value, 1.52; AUC, 0.80; 95%CI, 0.61–0.98). LDH, LAR, troponin I, and AAR are a group of promising biomarkers that demonstrate excellent predictive ability in predicting the 30-day mortality rate of immune-related myocarditis.


  • Open Access

    Screening and Bioinformatics Analysis of Crucial Gene of Heart Failure and Atrial Fibrillation Based on GEO Database

    by Yuansong Zhuang, Zhentao Qiao, Xuanye Bi, Dongjian Han, Qingjiao Jiang, Yi Zhang, Fuhang Wang, Miaomiao Liu, Quanxu An, Jiahong Shangguan, et al.

    Background and objectives: In clinical practice, we observed that the prognoses of patients with heart failure and atrial fibrillation were worse than those of patients with only heart failure or atrial fibrillation. The study aims to get a better understanding of the common pathogenesis of the two diseases and find new therapeutic targets. Materials and Methods: We downloaded heart failure datasets and atrial fibrillation datasets from the gene expression omnibus database. The common DEGs (differentially expressed genes) in heart failure and atrial fibrillation were identified by a series of bioinformatics methods. To better understand the functions and possible pathways of DEGs, we performed Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. Results: We identified 22 up-regulated genes and 14 down-regulated genes in two datasets of heart failure and 475 up-regulated and 110 down-regulated genes in atrial fibrillation datasets. In addition, two co-upregulated (FRZB, SFRP4) and three co-downregulated genes (ENTPPL, AQP4, C1orf105) were identified. GO enrichment results showed that these common differentially expressed genes were mainly concentrated in the signal regulation of the Wnt pathway. Conclusions: We found five crucial genes in heart failure and atrial fibrillation, which may be potential therapeutic targets for patients with heart failure and atrial fibrillation.